Treatment – POCN IBS-C Center of Excellence

Treatment

Secretagogues for IBS-C: Results from a Network Meta-analysis

This network meta-analysis evaluated the comparative efficacy and safety of secretagogues (linaclotide, lubiprostone, plecanatide, tenapanor) for treating IBS-C, analyzing data from 15 randomized controlled trials involving 8,462 patients....

Amy Stewart,

MSN, FNP-C
Capital Digestive Care

Linaclotide Significantly Improves Abdominal Symptoms in Patients With IBS-C

This randomized controlled trial investigated the effectiveness of linaclotide compared to placebo in reducing abdominal symptoms (bloating, discomfort, pain) in...

CURATED BY:
Amy Stewart,
MSN, FNP-C

Antidepressants and Psychological Therapies Effective in Treating IBS

This updated systematic review and meta-analysis aimed to assess the effectiveness of antidepressants and psychological therapies in treating irritable bowel...

CURATED BY:
Amy Stewart,
MSN, FNP-C

Amitriptyline Shows Significant Improvement in IBS Symptoms in Primary Care Setting

A multicenter, double-blind, placebo-controlled trial was conducted to determine if amitriptyline (10-30 mg nightly) is superior to placebo for improving...

CURATED BY:
Amy Stewart,
MSN, FNP-C

IBS Affects 10.5% of Population: Study Highlights Tricyclic Antidepressant Treatment

A community-based study in Birmingham, UK, found that IBS affects 10.5% of the population, with a higher prevalence in women...

CURATED BY:
Amy Stewart,
MSN, FNP-C

Low FODMAP Diet: A Key Strategy for Managing IBS Symptoms

FODMAPs are a group of short-chain carbohydrates (sugars) that are not fully digested or absorbed in the intestines....

CURATED BY:
Amy Stewart,
MSN, FNP-C

Gastroenterologists Embrace Dietary Therapy for IBS, Yet Dietitian Referrals Remain Low

A survey of United States gastroenterologists explored their perceptions of dietary therapies for managing irritable bowel syndrome (IBS)....

CURATED BY:
Amy Stewart,
MSN, FNP-C